Philip Sutera

5PUBLICATIONS
60CO-AUTHORS
Molecular targetsAdversarial machine learningRadiation therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 11, 2025
Integrating systemic therapy and metastasis-directed therapy in oligometastatic hormone-sensitive prostate cancer.

Xiaolei Shi, Jarey H Wang, Brian F Chapin

|Jul 03, 2025
Generative AI in Medicine: Pioneering Progress or Perpetuating Historical Inaccuracies? Cross-Sectional Study Evaluating Implicit Bias.

Philip Sutera, Rohini Bhatia, Timothy Lin

|May 07, 2025
Outcomes of Radium-223 and Stereotactic Ablative Radiotherapy Versus Stereotactic Ablative Radiotherapy for Oligometastatic Prostate Cancers: The RAVENS Phase II Randomized Trial.

Jarey H Wang, Alexander D Sherry, Soha Bazyar

|Jan 17, 2025
PSMA+ Extracellular Vesicles Are a Biomarker for SABR in Oligorecurrent Prostate Cancer: Analysis from the STOMP-like and ORIOLE Trial Cohorts.

Jack R Andrews, Yohan Kim, Edlira Horjeti

|Aug 24, 2022
Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE Trials.

Matthew P Deek, Kim Van der Eecken, Philip Sutera

Pageof 1

Frequent Collaborators

3 joint publications

Ryan Phillips

3 joint publications

Phuoc Tran

2 joint publications

Matthew P Deek

2 joint publications

Aurélie De Bruycker